ANCA-associated vasculitides: Pathogenetic aspects and current evidence-based therapy

被引：11
作者：
Holle, J. U. [1 ]
Gross, W. L.
机构：
[1] Univ Hosp Schleswig Holstein, Dept Rheumatol, D-23538 Lubeck, Germany
来源：
JOURNAL OF AUTOIMMUNITY | 2009年 / 32卷 / 3-4期
关键词：
ANCA-associated vasculitis; Wegener's granulomatosis; Evidence-based therapy; EULAR recommendations; CHURG-STRAUSS-SYNDROME; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; REFRACTORY WEGENERS-GRANULOMATOSIS; ANTIBODY-ASSOCIATED VASCULITIS; TNF-ALPHA BLOCKADE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TERM-FOLLOW-UP; RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; POLYARTERITIS-NODOSA;
D O I：
10.1016/j.jaut.2009.02.019
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A lot of progress has been made regarding the therapy of ANCA-associated vasculitides in the past decades. Cyclophosphamide still is standard therapy for remission induction in generalized disease, however, duration and cumulative dose of cyclophosphamide have been curtailed successfully to reduce toxicity. MTX is a safe alternative for remission induction in early systemic disease and medications available for remission maintenance have been extended. Rituximab and TNFalpha-antagonists represent promising options for refractory disease. The current evidence of therapy of ANCA-associated vasculitides is summarized in this review. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：163 / 171
页数：9
相关论文
共 50 条
[21]   ANCA-associated vasculitides-advances in pathogenesis and treatment [J].
Chen, Min ;
Kallenberg, Cees G. M. .
NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (11) :653-664
[22]   The role of rituximab in the treatment of ANCA-associated vasculitides (AAV) [J].
Daikeler, Thomas ;
Kistler, Andreas D. ;
Martin, Pierre-Yves ;
Vogt, Bruno ;
Huynh-Do, Uyen .
SWISS MEDICAL WEEKLY, 2015, 145
[23]   ANCA-Associated Vasculitides [J].
Stegert, Mihaela ;
Neumann, Thomas ;
Daikeler, Thomas .
THERAPEUTISCHE UMSCHAU, 2022, 79 (05) :229-237
[24]   Current Therapies for ANCA-Associated Vasculitis [J].
Lally, Lindsay ;
Spiera, Robert .
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 :227-240
[25]   Pathogenesis of ANCA-associated vasculitides in 2021: An update [J].
Neel, A. ;
Degauque, N. ;
Bruneau, S. ;
Braudeau, C. ;
Bucchia, M. ;
Caristan, A. ;
De Mornac, D. ;
Genin, V ;
Glemain, A. ;
Oriot, C. ;
Rimbert, M. ;
Brouard, S. ;
Josien, R. ;
Hamidou, M. .
REVUE DE MEDECINE INTERNE, 2022, 43 (02) :89-97
[26]   Advances in Therapy for ANCA-Associated Vasculitis [J].
Geetha, Duvuru ;
Seo, Philip .
CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) :509-515
[27]   Current Guidelines on ANCA-associated Vasculitides Common Features and Differences [J].
Hellmich, B. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (02) :133-142
[28]   French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides) [J].
Terrier, Benjamin ;
Darbon, Raphael ;
Durel, Cecile-Audrey ;
Hachulla, Eric ;
Karras, Alexandre ;
Maillard, Helene ;
Papo, Thomas ;
Puechal, Xavier ;
Pugnet, Gregory ;
Quemeneur, Thomas ;
Samson, Maxime ;
Taille, Camille ;
Guillevin, Loic ;
Audard, Vincent ;
Aumaitre, Olivier ;
Briot, Karine ;
Cacoub, Patrice ;
Cathebras, Pascal ;
Chauveau, Dominique ;
Chosidow, Olivier ;
Chouchana, Laurent ;
Cottin, Vincent ;
Cornec, Divi ;
Daugas, Eric ;
Diot, Elisabeth ;
Dupin, Nicolas ;
El Karoui, Khalil ;
Fain, Olivier ;
Gobert, Pierre ;
Guilpain, Philippe ;
Hamidou, Mohamed ;
Hummel, Aurelie ;
Jachiet, Marie ;
Jouneau, Stephane ;
Chiche, Noemie Jourde ;
Landron, Cedric ;
Le Jeunne, Claire ;
Lega, Jean-Christophe ;
Mariette, Xavier ;
Morel, Nathalie ;
Pagnoux, Christian ;
Remy, Philippe ;
Vandergheynst, Frederic .
ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (SUPPL 2)
[29]   ANCA-associated vasculitides State of the art [J].
Hellmich, B. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06) :518-528
[30]   Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? [J].
Tervaert, JWC ;
Heeringa, P .
NETHERLANDS JOURNAL OF MEDICINE, 2003, 61 (12) :404-407
12345